Home/Filings/4/0001645842-22-000131
4//SEC Filing

Singh Enakshi 4

Accession 0001645842-22-000131

CIK 0001645842other

Filed

Oct 18, 8:00 PM ET

Accepted

Oct 19, 6:01 PM ET

Size

14.1 KB

Accession

0001645842-22-000131

Insider Transaction Report

Form 4
Period: 2022-10-19
Singh Enakshi
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Stock Options

    2022-10-1949,2330 total
    Exercise: $10.14Exp: 2030-09-16Common Stock (49,233 underlying)
  • Disposition to Issuer

    Stock Options

    2022-10-19154,0000 total
    Exercise: $10.00Exp: 2031-10-26Common Stock (154,000 underlying)
  • Disposition to Issuer

    Common Stock

    2022-10-19462,2410 total
  • Disposition to Issuer

    Stock Options

    2022-10-1981,1320 total
    Exercise: $4.47Exp: 2027-08-10Common Stock (81,132 underlying)
  • Disposition to Issuer

    Stock Options

    2022-10-19173,9130 total
    Exercise: $26.88Exp: 2031-02-17Common Stock (173,913 underlying)
Footnotes (3)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 24, 2022 (the "Merger Agreement"), by and among Ginkgo Bioworks Holdings, Inc. ("Ginkgo"), Pepper Merger Subsidiary Inc. and the Issuer, each share of the Issuer's common stock was cancelled and converted into a right to receive 0.9179 of a share of Class A common stock of Ginkgo (the "Merger Consideration"), together with cash in lieu of any fractional shares of Class A common stock of Ginkgo.
  • [F2]At the effective time (the "Effective time") all outstanding unvested Issuer RSUs were cancelled and converted into RSUs of Ginkgo with respect to the number of shares of Class A common stock of Ginkgo determined by multiplying (i) the number of shares of Issuer common stock subject to such unvested Issuer RSUs as of immediately prior to the Effective Time by (ii) the Merger Consideration, rounded down to the nearest whole share, and otherwise subject to the same terms and conditions as were applicable to the Issuer RSUs immediately prior to the Effective Time (including applicable vesting conditions).
  • [F3]Immediately prior to the Effective Time, all outstanding Issuer stock options vested in full pursuant to the terms of the agreements governing such stock options. Pursuant to the Merger Agreement, at the Effective Time, each Issuer stock option with an exercise price per share equal to or greater than the Merger Consideration Value (as defined in the Merger Agreement) was cancelled for no consideration.

Issuer

Zymergen Inc.

CIK 0001645842

Entity typeother

Related Parties

1
  • filerCIK 0001846617

Filing Metadata

Form type
4
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 6:01 PM ET
Size
14.1 KB